Disposition of 1540 shares by Rajeev Singh of Accolade at 3.704 subject to Rule 16b-3

ACCD Stock  USD 3.79  0.07  1.81%   
About 66% of Accolade's investor base is looking to short. The analysis of the overall investor sentiment regarding Accolade suggests that many traders are alarmed. The current market sentiment, together with Accolade's historical and current headlines, can help investors time the market. In addition, many technical investors use Accolade stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Accolade Director, Officer: Chief Executive Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)

Read at macroaxis.com
Disposition of 1540 common stock at 3.704 of Accolade by Rajeev Singh on 2nd of October 2024. This event was filed by Accolade with SEC on 2024-10-02. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Accolade's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Accolade's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Accolade Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Accolade can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Accolade Fundamental Analysis

We analyze Accolade's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Accolade using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Accolade based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

Accolade is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

Accolade Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Accolade stock to make a market-neutral strategy. Peer analysis of Accolade could also be used in its relative valuation, which is a method of valuing Accolade by comparing valuation metrics with similar companies.

Peers

Accolade Related Equities

CMAXCareMax   130.00   
0%
100.0%
PRVAPrivia Health   3.86   
0%
2.0%
HCATHealth Catalyst   2.15   
0%
1.0%
CERTCertara   0.71   
0%
1.0%
NRCNational Research   0.56   
0%
1.0%
PHRPhreesia   0.33   
0%
1.0%
DHDefinitive Healthcare   0.21   
0%
1.0%
HSTMHealthStream   0.18   
0%
1.0%
PINCPremier   0.31   
1.0%
0%
EVHEvolent Health   1.63   
1.0%
0%

Complementary Tools for Accolade Stock analysis

When running Accolade's price analysis, check to measure Accolade's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accolade is operating at the current time. Most of Accolade's value examination focuses on studying past and present price action to predict the probability of Accolade's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accolade's price. Additionally, you may evaluate how the addition of Accolade to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios